Picture of Pro-Dex logo

PDEX — Pro-Dex News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Pro-Dex Inc expected to post earnings of 28 cents a share - Earnings Preview

* Pro-Dex Inc  PDEX.OQ   PDEX.O  is expected to show no change
in quarterly revenue when it reports  results on November 3
(estimated). 
* The Irvine, California-based company is expected to report  a
0.0% equal in revenue to $8.59 million from $8.59 million a year
ago, according to the estimate from one analyst, based on
Refinitiv data. 
​* Refinitiv's mean analyst estimate for Pro-Dex Inc is for
earnings of 28 cents per share. For the same quarter last year,
the company reported earnings of 32 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Pro-Dex Inc is
$39​, about 35.9% above​ its last closing price of $25.00. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 302021   0.29        0.29       0.22      Missed  -24.1
 Mar. 312021   0.22        0.22       0.50      Beat    127.3
 Dec. 312020               0.35       0.08      Missed  -77.1​
 Sep. 302020   0.33        0.33       0.32      Missed  -3
 ​​Jun.        0.18        0.18       0.63      Beat    250
 302020                                                 
 Mar. 312020   0.22        0.22       0.30      Beat    36.4​
 Dec. 312019   0.22        0.22       0.31      Beat    40.9
 Sep. 302019   0.27        0.27       0.27      Met     0
 This summary was machine generated November 2 at 02:07 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Pro-Dex

See all news